Is It Too Late to Get In on This Millionaire-Maker Stock?
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
Millions have been made this year by investors who bet on coronavirus vaccine stocks at the start of the pandemic -- or even earlier. Some clinical-stage biotech players offered tempting entry points. I'm talking share prices under $20. And, with work in this new field, these companies also offered great potential for gains.
A perfect example is Novavax (NASDAQ: NVAX). The biotech company's shares traded at about $4 in early January and since that time have soared more than 2,000%. In fact, if you had invested $25,000 back then, your holding would have been worth more than $1 million at the stock's peak in August. Now the question is whether an investment in Novavax today could still make you a bundle -- or if it's too late. Let's take a look.
Source Fool.com
